麻豆传媒

Gardini studies the epigenetic control of transcription during cell differentiation and oncogenesis. Born and raised in Italy, Gardini obtained a B.S./M.S. in medical biotechnology at the University of Bologna and attended the graduate school of Molecular Medicine at the University of Milan. He trained as a postdoctoral fellow with Dr. Ramin Shiekhattar at the Center of Genomic Regulation in Barcelona, The Wistar Institute and the University of Miami Medical School. He joined Wistar as an assistant professor in 2015. Gardini is a scholar of the Leukemia Research Foundation and the American Cancer Society.

Dr. Diego Hernández-Saavedra received his BS Degree in Pharmaceutical Biological Chemistry from the Autonomous University of Queretaro, Mexico in 2012. Thereafter, he completed his Ph.D. degree in Nutritional Sciences at the University of Illinois in 2018. After completing his Ph.D., he went to The Ohio State University Wexner Medical Center to complete his postdoctoral training in 2021. Dr. Hernández-Saavedra’s research program focuses on the beneficial effects of exercise to understand the adaptations in key metabolites and lipids in health and disease, the epigenetic mechanisms associated exercise that improve metabolism and bioenergetics, and the transgenerational effect of sedentarism and exercise on metabolism and cardiac function.

Enke researches development and diseases of retinal neurons, epigenetic regulation, genomics and bioinformatics, molecular biology and neuroscience. 
Enke is interested in the molecular processes that neuronal precursors undergo during development into mature retinal neurons, such as rod and cone photoreceptors. He also researches blinding diseases that afflict the retina, such as age-related macular degeneration. In 2018, Enke received $463,915 from the National Institutes of Health to investigate early clinical detectors of age-related macular degeneration and potential medical interventions if early detectors are discovered. 
Enke earned his bachelor's degree in biology from Salisbury University and his doctorate in biochemistry and molecular biology from Johns Hopkins School of Public Health.